Can Valium (diazepam) prolong the QT interval in patients, especially those with pre-existing cardiovascular disease or taking other QT-prolonging medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Valium Prolong the QT Interval?

No, Valium (diazepam) does not prolong the QT interval and is considered safe from a cardiac arrhythmia perspective. Benzodiazepines, including diazepam, are classified as "Class A" drugs without any risk of QT prolongation or torsades de pointes 1.

Evidence Supporting Benzodiazepine Safety

  • Benzodiazepines, which include diazepam, are explicitly classified as "Class A" drugs—considered to be without any risk of QT prolongation or torsades de pointes according to European Heart Journal guidelines 1.

  • In vitro studies have shown both inhibition and activation of potassium currents during benzodiazepine exposure, but critically, no changes in QT duration have been reported in clinical use 1.

  • Diazepam and other benzodiazepines are notably absent from comprehensive lists of QT-prolonging medications in major cardiology guidelines from the European Heart Journal and Circulation 1.

Clinical Implications for Patient Care

  • Diazepam can be safely used in patients with pre-existing QT prolongation, cardiovascular disease, or those taking other QT-prolonging medications without adding additional arrhythmia risk 1.

  • ECG monitoring is not specifically required when administering diazepam alone, even in high-risk cardiac patients 1.

  • When managing agitation or anxiety in patients with prolonged QTc intervals, benzodiazepines like diazepam represent a preferred alternative to antipsychotics, which frequently cause QT prolongation 2.

Contrast with Other Psychotropic Medications

Understanding the safety profile of benzodiazepines becomes clearer when compared to medications that do prolong QT:

Antipsychotics (High Risk)

  • Thioridazine causes 25-30 ms QTc prolongation and carries an FDA black box warning 2.
  • Haloperidol causes 7 ms QTc prolongation, with higher risk via IV administration 2.
  • Quetiapine causes 6 ms QTc prolongation 2.

Antidepressants (Moderate Risk)

  • Tricyclic antidepressants prolong QT and increase cardiac arrest risk (OR=1.69) 1.
  • SSRIs like citalopram have prompted FDA warnings about QT prolongation 1.

Benzodiazepines (No Risk)

  • Diazepam and lorazepam cause 0 ms QTc prolongation and are recommended as safe alternatives when QT concerns exist 1.

Important Clinical Context

While diazepam does not prolong QT, clinicians should remain aware of risk factors that do cause QT prolongation in critically ill patients:

  • Female gender, age >65 years, and bradycardia significantly increase QT prolongation risk with other medications 3, 4.
  • Electrolyte abnormalities (hypokalemia <4.5 mEq/L, hypomagnesemia) dramatically increase arrhythmia risk 3, 4.
  • Concurrent use of multiple QT-prolonging medications creates exponentially increased risk 3, 4.
  • Pre-existing cardiovascular disease or baseline QTc >500 ms represents high-risk situations 5, 4.

Practical Recommendations

  • Use diazepam without QT-related concerns in patients requiring anxiolysis or sedation, regardless of cardiac history 1.

  • Consider diazepam as a first-line agent for agitation in patients with prolonged QTc instead of antipsychotics 2.

  • When combining diazepam with QT-prolonging medications (such as haloperidol for severe agitation), the QT risk comes entirely from the non-benzodiazepine agent 1.

  • No specific cardiac monitoring is required for diazepam monotherapy, even in patients with known cardiac disease 1.

References

Guideline

QT Prolongation and Lorazepam Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antipsychotics and QTc Interval Prolongation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.